Novalis LifeSciences
Investor profile
Venture capital
Novalis LifeSciences has backed 2 European tech companies across 2 funding rounds in 2022, joining rounds totalling €127M. Most active in Healthtech. Data as of Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2022
1 yr
Total round €
€127M
sum of rounds joined
Deals by year
distinct rounds / yearNovalis LifeSciences — deals by year — interactive chart.
Data table
| Novalis LifeSciences — deals by year | |
|---|---|
| 2022 | 2 |
Top sectors
by dealsNovalis LifeSciences — top sectors — interactive chart.
Data table
| Novalis LifeSciences — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsNovalis LifeSciences — stages — interactive chart.
Data table
| Novalis LifeSciences — stages | |
|---|---|
| Series B | 2 |
Countries
by dealsNovalis LifeSciences — countries — interactive chart.
Data table
| Novalis LifeSciences — countries | |
|---|---|
| Belgium | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Ori Biotech | UK | 1 | €88M |
| eTheRNA | Belgium | 1 | €39M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Ori Biotech | Series B | €88M | 2022-01 |
| eTheRNA | Series B | €39M | 2022-08 |